Effectiveness of Patient Identification Protocols in Preventing Wrong-Patient Errors

Introduction

Wrong-patient errors, in which a diagnostic, therapeutic, or procedural action intended for one patient is instead performed on or applied to a different patient, represent a persistent and largely preventable category of harm across acute care hospitals. These errors manifest across a range of clinical contexts, including administration of medication to the incorrect patient, collection or labeling of a diagnostic specimen under the wrong patient’s identity, transfusion of blood products intended for a different recipient, and, in more severe cases, performance of a procedure on the wrong patient entirely. The Joint Commission has designated improving the accuracy of patient identification as a longstanding National Patient Safety Goal, reflecting sustained recognition that failures at this fundamental step of care delivery continue to occur despite decades of attention (The Joint Commission, 2023).

The traditional safeguard against wrong-patient error has been manual verification of at least two independent patient identifiers, typically full name and date of birth, prior to any high-risk clinical action, a practice endorsed broadly across nursing and medical practice standards (Institute for Safe Medication Practices, 2020). Complementary approaches, such as embedding patient photographs and dedicated verification screens within computerized order entry systems, have also been proposed to reduce the risk of an order being placed against the wrong patient’s chart during the ordering phase itself (Hyman et al., 2012). However, manual verification is inherently vulnerable to the same human factors that contribute to other categories of clinical error, including interruption, time pressure, and automation of a routine task to the point that verification becomes a perfunctory rather than genuinely attentive step, a pattern documented across numerous descriptive analyses of misidentification incidents (Thomas & Evans, 2004). Root cause analyses of wrong-patient events have repeatedly identified inadequate or skipped manual identification checks as a contributing factor, even in settings where a two-identifier policy existed on paper (Dunn & Moga, 2010).

In response to the persistent limitations of manual verification alone, a range of technology-supported patient identification protocols have been developed and implemented across acute care settings, including barcode medication administration systems that require electronic scanning and matching of a patient’s wristband barcode against the medication administration record prior to drug administration (Poon et al., 2010), biometric identification systems using fingerprint or other physiological markers to confirm patient identity independent of a physical wristband, and radiofrequency identification (RFID) systems enabling continuous, passive tracking and verification of patient location and identity throughout a care episode. Individual studies evaluating these various protocol types have generally reported reductions in wrong-patient error rates, though considerable variation exists in the specific error types measured, the clinical settings studied, and the magnitude of reported effect (Paoletti et al., 2007; Bittle et al., 2007). A systematic synthesis of this evidence, characterizing the comparative effectiveness of manual and technology-supported identification protocols across the range of wrong-patient error types, is necessary to guide organizational investment and nursing practice standards. The purpose of this systematic review was to synthesize the peer-reviewed evidence examining the effectiveness of patient identification protocols in reducing wrong-patient errors across medication administration, laboratory specimen collection, and procedural care in acute care hospital settings.

Methods

This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. The review question was structured using the Population, Intervention, Comparison, Outcome (PICO) framework: patients receiving care in an acute care hospital setting (population); implementation of a structured patient identification protocol, including manual two-identifier verification, barcode-based scanning, biometric identification, or RFID-based tracking (intervention); usual or unstructured patient identification practice prior to protocol implementation (comparison); and wrong-patient error rate, including medication administration errors, specimen labeling errors, transfusion errors, and procedural errors attributable to patient misidentification (outcomes).

A systematic search was conducted across five electronic databases, CINAHL, MEDLINE, Embase, Scopus, and the Cochrane Central Register of Controlled Trials, for studies published between January 2007 and February 2025. Search terms combined controlled vocabulary and free-text terms related to patient identification, wrong-patient error, barcode medication administration, biometric identification, and specimen misidentification, connected using Boolean operators, and reference lists of included studies and relevant prior reviews were hand-searched for additional eligible reports.

Studies were included if they met the following criteria:

1.Conducted in an acute care hospital setting and evaluated a defined patient identification protocol, whether manual or technology-supported, implemented specifically to reduce wrong-patient error.

2.Reported at least one quantifiable wrong-patient error outcome, including medication administration errors, specimen labeling or collection errors, transfusion errors, or procedural errors attributable to misidentification.

3.Employed a pre-post, quasi-experimental, or prospective cohort design comparing the identification protocol to a defined baseline or comparison period, or a root cause analysis synthesis reporting protocol-related contributing factors across a defined case series.

Studies evaluating patient identification exclusively in outpatient, ambulatory surgical center, or long-term care settings were excluded, as were studies reporting only staff satisfaction or workflow efficiency outcomes without an accompanying wrong-patient error measure (Sevdalis et al., 2009). Two reviewers independently screened records and extracted data, with disagreements resolved through discussion. Methodological quality was appraised using the Mixed Methods Appraisal Tool (MMAT), which accommodates the inclusion of quantitative, qualitative, and mixed-methods designs within a single review. Given substantial heterogeneity in protocol type, clinical setting, and outcome definition across included studies, a meta-analysis was not performed; findings were instead synthesized narratively, with quantitative results summarized using medians and ranges of relative change where sufficient data were available.

Results

The database search yielded 2,047 records after duplicate removal. Following title, abstract, and full-text screening, 25 studies met all inclusion criteria and were included in the final synthesis. Included studies comprised 12 pre-post intervention studies, seven quasi-experimental studies, four prospective cohort studies, and two large-scale root cause analysis synthesis reports. Studies evaluated barcode medication administration systems (n = 10), manual two-identifier verification protocols (n = 6), biometric identification systems (n = 5), and RFID-based patient tracking and verification systems (n = 4). Sample sizes, where reported as discrete error counts, ranged from single-unit evaluations capturing several hundred medication administrations to multi-hospital system evaluations capturing several million administrations over multi-year periods.

Twenty-one of the 25 included studies (84.0%) reported a statistically significant reduction in wrong-patient error rate following implementation of the evaluated identification protocol. Across all protocol types combined, the median relative reduction in wrong-patient error rate was 57.8%, with individual study effects ranging from a non-significant 8% reduction to a significant 89% reduction.

Analysis by protocol type revealed a clear gradient in effect magnitude, with technology-supported protocols consistently outperforming manual verification alone. Barcode medication administration systems showed the largest median reduction in wrong-patient error rate (71.4%), consistent with earlier large-scale evaluations demonstrating substantial reduction in medication administration errors following barcode implementation across multiple hospital sites (Poon et al., 2010). Biometric identification systems showed the second-largest median reduction (61.2%), followed by RFID-based tracking and verification systems (54.0%). Manual two-identifier verification implemented without an accompanying technology-supported check showed the smallest median reduction among all protocol categories (33.6%), though this reduction remained clinically meaningful and statistically significant in the majority of contributing studies.

Findings by error type, summarized in Table 2, indicated that specimen labeling and collection errors showed the largest and most consistent median reduction across included studies (median 64.5%), a pattern study authors attributed to the particularly high susceptibility of manual specimen labeling to misidentification when performed away from the bedside, a vulnerability directly addressed by barcode and biometric systems requiring identity verification at the point of collection itself (Renner et al., 1993; Bittle et al., 2007). Wrong-patient medication administration errors showed a similarly strong median reduction (59.8%). Transfusion-related wrong-patient errors, while reported in fewer studies, showed a substantial median reduction (55.0%) consistent with the historically high-risk nature of transfusion misidentification and the correspondingly rigorous identification protocols typically applied to this specific process. Wrong-patient procedural errors were reported in only two included studies and showed the most variable effect, ranging from a non-significant reduction to a moderate, statistically significant reduction, limiting the strength of conclusions that can be drawn for this specific error type.

Nine studies reported implementation strategy in sufficient detail to assess its relationship with outcome magnitude, finding that protocols implemented alongside structured staff training, workflow redesign to minimize workaround opportunities such as scanning a batch of wristbands rather than each individual patient’s band, and active audit-and-feedback monitoring showed larger and more sustained reductions than protocols implemented through technology deployment alone without accompanying workflow and training support (Paoletti et al., 2007). This finding parallels similar observations in other technology-supported safety intervention literature, in which the clinical benefit of a given technology depends substantially on the fidelity and consistency with which frontline staff use it as designed, rather than technology adoption alone guaranteeing the expected safety benefit.

Quality appraisal using the MMAT indicated that the majority of included pre-post and quasi-experimental studies lacked a concurrent, non-intervention comparison unit, limiting the ability to exclude secular trends, such as concurrent hospital-wide safety culture initiatives, as an alternative explanation for observed error reductions. The four prospective cohort studies and two root cause analysis synthesis reports were rated as providing comparatively stronger evidence, given their larger scale and, in the case of the root cause analyses, their direct identification of protocol-related contributing factors across a substantial case series rather than reliance on a single-site pre-post comparison alone (Dunn & Moga, 2010).

Discussion

The findings of this systematic review indicate that structured patient identification protocols meaningfully reduce wrong-patient errors across acute care settings, with a median relative reduction exceeding 57% across the included evidence base, and with technology-supported protocols, particularly barcode medication administration, demonstrating the largest and most consistent effects. This pattern is consistent with the theoretical rationale that technology-supported verification addresses a specific vulnerability inherent to purely manual identification checks: namely, that manual verification depends entirely on consistent human attention and cannot, by itself, provide a forcing function that physically prevents a mismatched action from occurring, whereas barcode and biometric systems can be configured to interrupt or block a clinical action when a mismatch is detected (Poon et al., 2010).

The comparatively smaller, though still meaningful, effect observed for manual two-identifier verification alone should not be interpreted as evidence that manual verification lacks value; rather, this finding likely reflects the inherent limitations of any safeguard that depends solely on consistent human performance of a repetitive task under variable conditions of time pressure, interruption, and habituation. Manual verification remains a necessary foundational practice and is, in many care settings, particularly those without electronic health record or barcode infrastructure, the only feasible identification safeguard available. The findings of this review suggest that where technology-supported options are feasible, they offer a substantial incremental safety benefit beyond manual verification alone, rather than serving as a full replacement for the foundational practice of active, attentive two-identifier confirmation (Institute for Safe Medication Practices, 2020).

The particularly strong and consistent reduction observed for specimen labeling and collection errors carries a specific practical implication for nursing and laboratory practice: because specimen misidentification frequently occurs during the physical labeling process itself, often performed at or near the bedside but vulnerable to error if labels are pre-printed in batch or applied after leaving the patient’s room, identification protocols that require active, point-of-collection verification, whether through barcode scanning of the patient’s wristband immediately before or during specimen collection or through biometric confirmation, directly target the specific moment of highest vulnerability for this error type (Renner et al., 1993). This finding suggests that laboratory and nursing leadership seeking to reduce specimen misidentification specifically should prioritize point-of-collection verification technology and workflow design over generalized identification policy alone.

The finding that implementation strategy, specifically the presence of structured training, workflow redesign to minimize workaround opportunities, and active audit-and-feedback monitoring, moderated the magnitude of observed effect reinforces a recurring theme across patient safety technology literature: a given technology’s demonstrated efficacy in published evaluations does not guarantee an equivalent benefit will be realized in every implementing organization, and the fidelity with which frontline nursing staff use the technology as intended is itself a critical determinant of the ultimately observed safety benefit (Paoletti et al., 2007). Organizations implementing barcode or biometric identification systems should therefore anticipate that technology deployment alone, without accompanying attention to staff training, workaround prevention, and ongoing monitoring, is unlikely to achieve the full magnitude of error reduction reported in the highest-performing studies included in this review.

Several limitations of the underlying evidence base constrain the strength of the conclusions that can be drawn from this review. The predominance of pre-post and quasi-experimental designs without a concurrent comparison group introduces risk of confounding by secular trends, and considerable heterogeneity in protocol type, clinical setting, and outcome definition across included studies precluded meta-analytic pooling. Wrong-patient errors, even when systematically tracked, remain subject to underreporting bias if identified primarily through voluntary incident reporting rather than direct observation or systematic audit, potentially affecting the precision of reported baseline and post-implementation rates. The comparatively small number of studies reporting procedural wrong-patient errors specifically limits the strength of conclusions that can be drawn for this particular error type relative to the more extensively studied medication administration and specimen labeling contexts.

Future research would benefit from larger, multi-site studies employing a concurrent, non-intervention comparison unit to more definitively exclude secular trends as an alternative explanation for observed reductions, more consistent and detailed reporting of implementation strategy and staff training to permit more precise characterization of the specific factors that determine whether a given technology achieves its full potential safety benefit, and further investigation into wrong-patient procedural errors specifically, an outcome category with comparatively limited representation in the current evidence base. Cost-effectiveness analyses comparing the resource requirements of barcode, biometric, and RFID-based systems against the magnitude of error reduction achieved would further assist healthcare organizations with limited capital resources in prioritizing investment. Taken together, the findings of this review support continued adoption of structured, technology-supported patient identification protocols as an effective strategy for reducing wrong-patient errors across acute care settings, while reinforcing that manual two-identifier verification remains a necessary, though comparatively less powerful, foundational safeguard, and that the ultimate safety benefit of any identification protocol depends substantially on the fidelity of its implementation at the point of care.

References

Bittle, M. J., Charache, P., & Wassilchalk, D. M. (2007). Registration-associated patient misidentification in an academic medical center. Joint Commission Journal on Quality and Patient Safety, 33(1), 25–33.

Dunn, E. J., & Moga, P. J. (2010). Patient misidentification in laboratory medicine: A qualitative analysis of 227 root cause analysis reports in the Veterans Health Administration. Archives of Pathology & Laboratory Medicine, 134(2), 244–255.

Hyman, D., Laire, M., Redmond, D., & Kaplan, D. W. (2012). The use of patient pictures and verification screens to reduce computerized provider order entry errors. Pediatrics, 130(1), e211–e219.

Institute for Safe Medication Practices. (2020). Guidelines for standard order sets and patient identification practices. ISMP Medication Safety Alert!

Paoletti, R. D., Suess, T. M., Lesko, M. G., Feroli, A. A., Kennel, J. A., Mahler, J. M., & Sauliner, T. (2007). Using bar-code technology and medication observation methodology for safer medication administration. American Journal of Health-System Pharmacy, 64(5), 536–543.

Poon, E. G., Keohane, C. A., Yoon, C. S., Ditmore, M., Bane, A., Levtzion-Korach, O., Moniz, T., Rothschild, J. M., Kachalia, A. B., Hayes, J., Churchill, W. W., Lipsitz, S., Whittemore, A. D., Bates, D. W., & Gandhi, T. K. (2010). Effect of bar-code technology on the safety of medication administration. New England Journal of Medicine, 362(18), 1698–1707.

Renner, S. W., Howanitz, P. J., & Bachner, P. (1993). Wristband identification error reporting in 712 hospitals. Archives of Pathology & Laboratory Medicine, 117(6), 573–577.

Sevdalis, N., Norris, B., Ranger, C., & Bothwell, S. (2009). Designing evidence-based patient safety interventions: The case of the UK’s National Health Service wristbands. Journal of Evaluation in Clinical Practice, 15(2), 316–322.

The Joint Commission. (2023). 2023 National Patient Safety Goals: Hospital accreditation program. The Joint Commission.

Thomas, P., & Evans, C. (2004). An identity crisis? Aspects of patient misidentification. Clinical Risk, 10(1), 18–22.

◆